Your session is about to expire
← Back to Search
transcranial direct current stimulation (tDCS) for Depression (tDCSintensif Trial)
tDCSintensif Trial Summary
This trial will study whether a 10-day intensive course of transcranial direct current stimulation (tDCS) is safe and feasible for treating major depressive disorder.
- Depression
tDCSintensif Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.tDCSintensif Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have a significant existing medical or neurological condition.You have been diagnosed with bipolar disorder.You have a mental health condition called psychosis.You have a personality disorder.You have a problem with thinking, memory, or understanding things.You have been using drugs excessively or in a harmful way in the last three months.You are at a high risk of trying to hurt yourself or taking your own life.You have been diagnosed with severe depression for at least 4 weeks, as determined by specific guidelines used by doctors.
- Group 1: Active tDCS
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are investigators currently recruiting participants for this investigation?
"Confirmed. As stated on clinicaltrials.gov, this medical investigation is actively looking for participants; it was initially posted on February 2nd 2022 and last modified on the 9th of that same month. The team needs 30 people to enrol at a single site."
What type of patient is best suited to participate in this investigative trial?
"Patients that meet the trial's inclusion criteria, i.e., those suffering from psychosis and aged between 18-65 years old, may be selected for the clinical trial; 30 total participants are needed in total."
What are the main aims of this research endeavor?
"The primary objectives of this 10-day medical trial are to assess adherence to tdcs and measure response rate (>50% improvement) with GRID-Hamilton Depression Rating Scale (GRID-HAMD). Secondary aims include assessing patient's change in General Anxiety Disorder (GAD-7), Hamilton Rating Scale for Depression (HAMD-6) symptoms, as well as remission rates (<7 on the scale where 0 is non depressed, very severe >23)."
Does the criterion for this research project include individuals over 30 years of age?
"This trial is seeking applicants aged between 18 and 65. For those below the age of majority, there are 106 studies available while 594 trials exist for patients above retirement age."
How many participants are enrolled in this experiment?
"Indeed, the data hosted on clinicaltrials.gov reveals that this medical study is currently enrolling patients. The trial was posted to the website in February 2nd 2022 and has been updated most recently on February 9th 2022; 30 individuals are sought from one site."
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger